Literature DB >> 7469551

Choledochoduodenostomy, choledochojejunostomy or sphincteroplasty for biliary and pancreatic disease.

D P Vogt, R E Hermann.   

Abstract

Choledochoduodenostomy, choledochojejunostomy, or sphincteroplasty are used in the treatment of selected patients with retained, recurrent, and impacted bile duct stones; strictures of the bile ducts; stenosis of the sphincter of Oddi; pancreatitis associated with biliary disease; choledochal cysts; fistulas of the bile duct; and biliary obstruction, either benign or malignant. From a group of approximately 1600 patients operated on for biliary and pancreatic disease during the 17-year period, 1962 to 1979, 153 patients who had choledochoduodenostomy, choledochojejunostomy or sphincteroplasty were identified. Follow-up information was available for 146 patients (95%). Overall, 84% of the patients had good results, 10% had fair results, and 3% had poor results. A 3% postoperative mortality rate was found, all in patients with unresectable malignancies. Treatment of bile duct obstruction, benign or malignant, was equally effective by choledochoduodenostomy or choledochojejunostomy. Jaundice resolved in all patients; three patients with benign strictures required reoperations for recurrent stricture formation, two after choledochoduodenostomy, and one after choledochojejunostomy. Recurrent cholangitis heralded the development of another stricture. Both choledochoduodenostomy and sphincteroplasty were used for patients with retained, recurrent or impacted duct stones. Pancreatitis did not occur in any patient after sphincteroplasty; the sump syndrome was not seen after choledochoduodenostomy. This review supports the view that choledochoduodenostomy is a safe and effective procedure. All three operative procedures were effective for the problems for which they were used; each procedure has a place in the treatment of recurrent or complicated biliary and pancreatic diseases. The procedures are complementary, not competitive. For certain problems, the operation performed depends upon the surgeon's preference and experience. The indications for and results of these operative procedures are discussed.

Entities:  

Mesh:

Year:  1981        PMID: 7469551      PMCID: PMC1345035          DOI: 10.1097/00000658-198102000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  Roux-en-Y hepaticojejunostomy: a reappraisal of its indications and results.

Authors:  P Stefanini; M Carboni; N Patrassi; A Basoli; G de Bernardinis; P Negro
Journal:  Ann Surg       Date:  1975-02       Impact factor: 12.969

2.  THE ROLE OF CHOLEDOCHODUODENOSTOMY IN COMMON DUCT SURGERY: REAPPRAISAL.

Authors:  A HURWITZ; G A DEGENSHEIN
Journal:  Surgery       Date:  1964-12       Impact factor: 3.982

3.  Sphincteroplasty and choledochoduodenostomy for benign biliary obstructions.

Authors:  R H Rutledge
Journal:  Ann Surg       Date:  1976-05       Impact factor: 12.969

4.  Choledochoduodenostomy in the treatment of benign biliary tract disease.

Authors:  H Freund; I Charuzi; G Granit; Y Berlatzky; Z Eyal
Journal:  Arch Surg       Date:  1977-09

5.  Palliation of malignant obstruction of the common bile duct by side to side choledochoduodenostomy.

Authors:  M Stuart; T Keo; R E Hermann; S O Hoerr
Journal:  Am J Surg       Date:  1971-05       Impact factor: 2.565

6.  Stenosis of the sphincter of Oddi.

Authors:  W W Shingleton; D Gamburg
Journal:  Am J Surg       Date:  1970-01       Impact factor: 2.565

7.  Choledochoduodenostomy. In the treatment of stenosis in the distal common duct.

Authors:  T Farrar; M W Painter; R Betz
Journal:  Arch Surg       Date:  1969-04

8.  Transduodenal sphincteroplasty (not sphincterotomy) for biliary and pancreatic disease. Indications, contraindications, and results.

Authors:  S A Jones; R A Steedman; T B Keller; L L Smith
Journal:  Am J Surg       Date:  1969-08       Impact factor: 2.565

9.  Peptic ulcer disease after choledochojejunostomy.

Authors:  M S McArthur; W P Longmire
Journal:  Am J Surg       Date:  1971-08       Impact factor: 2.565

10.  Indications for choledochoduodenostomy.

Authors:  W V Hagan; J B Thigpen; L A Smith; J R Groover; L F Urdaneta; S E Stephenson
Journal:  Am Surg       Date:  1978-11       Impact factor: 0.688

View more
  9 in total

Review 1.  Choledochoduodenostomy. Analysis of 71 cases followed for 5 to 15 years.

Authors:  A Escudero-Fabre; A Escallon; J Sack; N B Halpern; J S Aldrete
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

2.  Operative management of recurrent choledocholithiasis.

Authors:  Kazuhide Matsushima; David I Soybel
Journal:  J Gastrointest Surg       Date:  2012-08-21       Impact factor: 3.452

3.  Experience with sphincteroplasty and sphincterotomy in pancreatobiliary surgery.

Authors:  T M Anderson; H A Pitt; W P Longmire
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

4.  Is choledochoduodenostomy in the treatment of stones in the common bile duct an obsolete technique?

Authors:  L Cubillos; R Fiallo; J Rodriguez
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

5.  Indication and surgical techniques of bypass choledochojejunostomy for intractable choledocholithiasis.

Authors:  Shin Hwang; Dong-Hwan Jung; Sung Koo Lee; Myung-Hwan Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-05-31

6.  Biliary strictures complicating pancreaticoduodenectomy.

Authors:  B J Ammori; S Joseph; M Attia; J P Lodge
Journal:  Int J Pancreatol       Date:  2000-08

7.  Transduodenal sphincteroplasty and transampullary septectomy for postcholecystectomy pain.

Authors:  F G Moody; J M Becker; J R Potts
Journal:  Ann Surg       Date:  1983-05       Impact factor: 12.969

8.  Long term follow-up of patients with side to side choledochoduodenostomy and transduodenal sphincteroplasty.

Authors:  A R Baker; J P Neoptolemos; T Leese; D C James; D P Fossard
Journal:  Ann R Coll Surg Engl       Date:  1987-11       Impact factor: 1.891

9.  Is It Really SUMP Syndrome? A Case Report.

Authors:  Mohamed S Suliman; Monider M Singh; Kamran Zaheer; Saad Ullah Malik; Ahmad Abu-Hashyeh
Journal:  Cureus       Date:  2019-10-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.